Status:
UNKNOWN
NIV and CPAP Failure Predictors in COVID-19 Associated Respiratory Failure
Lead Sponsor:
Hospital General Universitario Morales Meseguer
Conditions:
Respiratory Failure
Covid-19
Eligibility:
All Genders
18+ years
Brief Summary
Evaluate HACOR socre utility and efficacy in predicting NIV and/or CPAP failure in patients with COVID-19 associated respiratory failure. Propose adaptations to HACOR score based on the "state of art...
Detailed Description
Evaluate HACOR socre utility and efficacy in predicting NIV and/or CPAP failure in patients with COVID-19 associated respiratory failure. Propose adaptations to HACOR score based on the "state of art...
Eligibility Criteria
Inclusion
- Patients with acute respiratory failure due to COVID-19 who have initiated NIV or CPAP based on assistant clinician decision
Exclusion
- Patients with imediate indication to invasive mechanical ventilation
- Patients with any formal contraindication to noninvasive respiratory support
Key Trial Info
Start Date :
April 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 15 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04342104
Start Date
April 1 2020
End Date
November 15 2021
Last Update
August 30 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital General Universitario Morales Meseguer
Murcia, Spain